Refine by Content Type
Refine by Year
Choose Sites to Search:
Point/Counterpoint: Is Interventional Oncology Ready to Stand on Its Own?
Interventional oncology sets aim on becoming the fourth pillar in the treatment of cancer.
With Michael C. Soulen, MD, FSIR, FCIRSE; Andreas Adam, MB, BS; and Lizbeth Kenny, MB, BS
Cost-Benefit Analysis of Critical Limb Ischemia in the Era of the Affordable Care Act
Is it fiscally responsible to perform primary amputation as treatment?
By Mary L. Yost, MBA